The discovery that the vast majority of HCL cases harbor the BRAF V600E mutation and that this mutation is absent in virtually all other indolent B-cell neoplasms makes detection of this mutation a strong indicator of HCL [40,41,42,43]. This evidence concerns the gene BRAF and hairy cell leukemia.